MoonLake Immunotherapeutics (MLTX) Non Operating Income (2021 - 2023)

MoonLake Immunotherapeutics' Non Operating Income history runs 3 years deep, the most recent figure standing at $1.4 million for Q3 2023.

• In Q3 2023, Non Operating Income rose 3587.69% year-over-year to $1.4 million; the TTM figure through Sep 2023 stood at $3.2 million (up 999.27% YoY), while the FY2022 annual figure was $591732.0, up 2036.91% from the prior year.
• Non Operating Income was $1.4 million for Q3 2023 at MoonLake Immunotherapeutics, up from $842652.0 in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $1.4 million in Q3 2023 to a low of -$61848.0 in Q4 2021.
• Historically, Non Operating Income has averaged $315966.8 across 3 years, with a median of $69506.0 in 2022.
• The sharpest annual moves came in 2022 and 2023: Non Operating Income soared 6584.92% in 2022, then jumped 243.76% in 2023.
• A 3-year view of Non Operating Income shows it stood at -$61848.0 in 2021, then surged by 487.25% to $239505.0 in 2022, then surged by 478.82% to $1.4 million in 2023.
• The last three Non Operating Income figures came in at $1.4 million (Q3 2023), $842652.0 (Q2 2023), and $723589.0 (Q1 2023), per Business Quant data.